CDMO Live Europe 2026

CDMO Live Europe 2026
Go back

CDMO Live Europe 2026 

19-21 May 2026, Rotterdam

Join Europe’s Premier External Manufacturing Community at CDMO Live 2026

We are pleased to offer BioRN members 20% discount for CDMO Live Europe

CDMO Live Europe 2026 is the global meeting place for leaders in outsourced biopharma development and manufacturing.

Across three days in Rotterdam, you’ll gain actionable insights, connect with partners through curated one-to-one meetings, and experience networking like no other.

550+ external manufacturing leaders and 90+ CDMOs are gathering at CDMO Live Europe (19-21 May, Rotterdam) – the most valuable and efficient event for external manufacturing in 2026.

Our commitment is that no other external manufacturing event will give you more strategic value in 2026.

Tickets include:

  • Training Sessions – Biotech CMC Bootcamp and Strategic Partnership training sessions designed for practical application, not theory
  • PartnerMatch meetings – Pre-scheduled 1-2-1s with 90+ CDMOs matching your specific requirements. No wasted conversations.
  • 20 Outsourcing Excellence Roundtables – Peer-led discussions on supplier management, capacity planning, AI in manufacturing and Decarbonization with the PSCI
  • 40+ Manufacturing Experts Across 3 Tracks featuring analysts and executives from MSD, Roche, AstraZeneca, Daiichi Sankyo, Sandoz, J&J, Bayer and leading biotech companies
  • Unique Networking Experiences – including Cycle Tour, Rotterdam Run, and the exclusive Boat Party to create connections

Find out more: https://pharmasource.global/events/cdmolive/

 

BioRN members receive a 20 % discount.

Please contact Nicole Hecht (nh(at)biorn.org) for the Discount Code and more Information.

register now

Our latest News

discover more
How is TR-FRET Used in Drug Discovery?

How is TR-FRET Used in Drug Discovery?

This post is Part 2 of a two-part blog series. Read part 1: What is a TR‑FRET assay and how is it used in drug discovery? In a previous blog post, we covered the fundamental principles of Time-Resolved Fluorescence (TR) Förster Resonance Energy Transfer (TR-FRET), including how long-lived lanthanide donors like europium enable high-sensitivity, “mix-and-read” assays. Because TR-FRET provides a ratiometric, proximity-based […]

read more
Triple ERC Success at the German Cancer Research Center

Triple ERC Success at the German Cancer Research Center

Three researchers at the German Cancer Research Center (DKFZ) have each been awarded a Starting Grant from the European Research Council (ERC) this year. Daniel Kirschenbaum, Lena Kutscher, and Michael Scherer impressed the ERC with their innovative research approaches to fundamental questions in cancer medicine. With the funding, they plan to investigate why certain brain […]

read more
Cancer Cachexia: How a Tumor Protein Drives Wasting in the Body

Cancer Cachexia: How a Tumor Protein Drives Wasting in the Body

Researchers at Helmholtz Munich, the Heidelberg Faculty of Medicine at Heidelberg University, the German Center for Diabetes Research (DZD) and the Technical University of Munich (TUM) have identified a previously unknown mechanism that can drive cancer cachexia – a wasting process in the body that primarily affects muscle and fat tissue. A central role is […]

read more

GET IN TOUCH

Stay Updated with bioRN’s Newsletter

Sign up for our newsletter to discover more!
* required

BioRN (BioRN Network e.V. and BioRN Cluster Management GmbH) will use the information you provide on this form to be in touch with you and to provide updates and marketing. Please let us know all the ways you would like to hear from us:

You can update your subscription preferences or unsubscribe at any time. Just follow the unsubscribe or update link in the footer of automated emails you receive from us, or by contacting us at info@biorn.org. We will treat your information with respect. For more information about our privacy practices please visit our website: www.biorn.org. By clicking below, you agree that we may process your information in accordance with these terms.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices.

Intuit Mailchimp